A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis
Lymphangioleiomyomatosis (LAM) is characterised by lung cysts and airflow obstruction. Matrix metalloproteinases have been implicated in lung destruction in LAM. We performed a randomised, double-blind trial, comparing the matrix metalloproteinases inhibitor doxycycline with placebo on the progressi...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Published: |
European Respiratory Society
2014
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/31531/ |